The role of amyloid beta peptide 42 in Alzheimer's disease.
about
Ubiquilin-1 is a molecular chaperone for the amyloid precursor proteinPossible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's diseaseEpigenetics of Alzheimer's disease and frontotemporal dementiaOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseAftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases.Recombinant amyloid beta-peptide production by coexpression with an affibody ligand.Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels.Xanthoceraside ameliorates mitochondrial dysfunction contributing to the improvement of learning and memory impairment in mice with intracerebroventricular injection of aβ1-42.Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early InterventionInhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitratesEffects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: Fura-2AM measurements and stochastic model simulationsIdentification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780.Heat shock protein 70 (hsp70) as an emerging drug target.A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.One-carbon metabolism and Alzheimer's disease: focus on epigeneticsMetabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like ratsSex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease.Amyloid-beta: a crucial factor in Alzheimer's disease.Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa.Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 miceToll-like receptors in Alzheimer's diseaseIncreased accumulation of intraneuronal amyloid beta in HIV-infected patients.Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitro.Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation.Cerebral microvascular rather than parenchymal amyloid-β protein pathology promotes early cognitive impairment in transgenic miceSpecific Triazine Herbicides Induce Amyloid-β42 Production.Studies on the interactions of copper and zinc ions with β-amyloid peptides by a surface plasmon resonance biosensor.Fine mapping of the amyloid β-protein binding site on myelin basic protein.Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial.Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects.Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease.Relevance of transgenic mouse models to human Alzheimer disease.Alzheimer's disease and tauopathy studies in flies and worms.Mitochondrial preconditioning: a potential neuroprotective strategy.Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.Animal models of Alzheimer disease.Latest Study on the Relationship between Pathological Process of Inflammatory Injury and the Syndrome of Spleen Deficiency and Fluid Retention in Alzheimer's Disease.
P2860
Q24634983-15616CA7-F3F3-41E2-8834-D4C5CD61D5EEQ24642355-5787A0CB-89AA-4847-8351-18788B8D804BQ27010153-FF28E17F-F6B2-474E-AAB8-F1CBB0DF1D68Q27023315-BD148963-3DEA-4E49-A814-86422AC1A6ADQ28828789-5AF271C1-9CA0-4F8C-948F-AEA31CD77B02Q30319326-B42F7B16-33BF-4AE5-A289-8D0564989BDEQ33381404-334F03A3-46C8-4BA2-B4B6-E78CF17D7FEBQ33496258-118B249B-FC21-49F1-BF7E-02DBABD8AC4EQ33757597-B93ECE1B-97C7-4806-9D1A-DA0C7AF1702AQ33838291-1262C00B-BF18-4B02-ACF8-F8D38D394B75Q33846317-5B0488DD-FCBA-4FAA-921B-04EF559148CFQ33868997-F7FE8060-E0D9-4F8E-BEC2-FF358D6FD0BEQ33944771-6CDD1DBD-4E29-4916-8C90-90B2DBE34E02Q33956906-FCED3257-A3FF-4BA6-92F7-E8488AE73ED4Q34079353-DFB71361-18AF-4093-B7AC-8A1AAA1345A4Q34094250-5CA04FB5-E4CC-4EEF-B11A-01D78554487FQ34095065-DEDA80DF-36B6-4F83-BCBE-17DAEA9EDCE5Q34332342-FCC482C8-6BBE-43F7-8691-4279952D340FQ34451907-475EEF38-8C63-4798-935E-A61DFA01F0B6Q34498158-938D3000-4A90-419D-83F0-CA87E9F6124CQ34516687-2191174F-AE23-4229-B753-E64E878F2B74Q34548586-13BBEAF4-1FA5-4F7C-94BC-94942125DA17Q34661343-7628EEA0-1882-4C44-ACD7-A47D1FBDC9C2Q35199200-C2E6FBF8-D504-4501-8660-BEFA3BACAD9EQ35256535-DB2B4886-3F8D-4273-AF9A-8ECFE2B2B685Q35646239-2BB0D35C-870A-469A-8D87-2B98DB136CEFQ36051548-766150F4-7E83-4AF8-B936-D4E441CAA460Q36121757-C05D5597-3993-4ABE-B2D3-BD225E849156Q36321873-33150174-B582-4EB9-A44D-73699CD0B92AQ36806584-F2DDA57F-5C55-4044-8632-21A908951260Q36827322-D1DC57A0-1BED-4689-8F6F-DC2F8DFCD4B1Q37009939-840B74B5-A2F5-4679-B74D-960B1E8D58AEQ37062579-BC314B04-4F03-47C4-9E42-3A015BB6B572Q37124928-27DBE4E9-135A-460C-B98E-FC6328DDA1FCQ37307236-8A1CB73F-CDA7-4C73-A519-E065C8A74BC5Q37715058-8CEA25F9-B03B-4B11-91EA-3EAD18D1FD98Q37788545-7A5BF37C-925B-420B-8F0B-495521054C59Q37859076-9DD38254-98B8-457A-9211-7186A85211D2Q38045853-09A5A824-D521-4740-A4CE-47CFDF7DB030Q38209663-729A7662-52EF-419B-9EB0-F25A05FB007A
P2860
The role of amyloid beta peptide 42 in Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The role of amyloid beta peptide 42 in Alzheimer's disease.
@ast
The role of amyloid beta peptide 42 in Alzheimer's disease.
@en
The role of amyloid beta peptide 42 in Alzheimer's disease.
@nl
type
label
The role of amyloid beta peptide 42 in Alzheimer's disease.
@ast
The role of amyloid beta peptide 42 in Alzheimer's disease.
@en
The role of amyloid beta peptide 42 in Alzheimer's disease.
@nl
prefLabel
The role of amyloid beta peptide 42 in Alzheimer's disease.
@ast
The role of amyloid beta peptide 42 in Alzheimer's disease.
@en
The role of amyloid beta peptide 42 in Alzheimer's disease.
@nl
P1476
The role of amyloid beta peptide 42 in Alzheimer's disease.
@en
P2093
Mark A Findeis
P304
P356
10.1016/J.PHARMTHERA.2007.06.006
P577
2007-07-17T00:00:00Z